Results 141 to 150 of about 297,779 (263)
Case series of dermopathy in autoimmune thyroid disease [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"Graves' disease (GD) is an autoimmune disease that can affect other tissues in addition to the thyroid gland. The clinical manifestations are a result of the impact of TSH receptor antibodies.
Janić Tamara +8 more
doaj +1 more source
Effect of Botulinum Toxin-A Injection on Intraocular Pressure and Proptosis in Thyroid Associated Orbitopathy [PDF]
, 2009 The aim of this study was to evaluate the effects of extraocular muscle injection of botulinum toxin-A (BTX-A) on intraocular pressure (IOP) and proptosis in patients with ocular motility disturbances in thyroid associated orbitopathy (TAO).
Davor Galetović +6 more
core +1 more source
What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review [PDF]
, 2014 Background: Thyroid eye disease (TED) causes a number of esthetic and visual problems and its treatment requires close clinical assessment, often for several years.
Bahmani-Kashkouli M +11 more
core +1 more source
Diagnosis of Graves’ Orbitopathy
, 2023 AbstractThe diagnosis of Graves’ orbitopathy is based on a typical clinical presentation, supported by a family history of Graves’ disease, in combination with typical findings on CT or MRI scans and/or elevated serum levels of TSH-receptor-binding immunoglobulins and anti-thyroid peroxidase.
openaire +2 more sources
The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy
Клиническая и экспериментальная тиреоидология, 2012 There was investigated the relationship between the clinical features of the diplopia in patients with the Graves’ orbitopathy and the specific signs of the orbit obtained by the multi-slice CT scanning in the study.
doaj +1 more source
Building the case for insulin-like growth factor receptor-I involvement in thyroid-associated ophthalmopathy [PDF]
, 2017 The pathogenesis of orbital Graves' disease (GD), a process known as thyroid-associated ophthalmopathy (TAO), remains incompletely understood. The thyrotropin receptor (TSHR) represents the central autoantigen involved in GD and has been proposed as the ...
Janssen, J.A.M.J.L. (Joop) +1 more
core +4 more sources
Selenium improves mild Graves’Orbitopathy: a randomized, double-blind, placebo-controlled study. [PDF]
, 2011 Background Free oxygen radicals and cytokines play a pathogenic role in Graves’ orbitopathy (GO). This study reports the results of a randomized, double-blind, placebo-controlled trial on the effect of selenium, an antioxidant agent, or pentoxifylline ...
ALTEA, MARIA ANTONIETTA
core
Endoscopic transnasal orbital decompression for thyrotoxic orbitopathy [PDF]
, 2002 Objective. To evaluate the efficacy of endoscopic transnasal orbital decompression alone for thyrotoxic orbitopathy. Design. Retrospective review of consecutive procedures. Setting. Tertiary referral otorhinolaryngology centre. Patients.
Chan, E +4 more
core
Archives of Endocrinology and MetabolismObjective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the
Mira Siderova +2 more
doaj +1 more source
Clinical Case Reports, 2018 Key Clinical Message A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell
Luminita Nicoleta Cima +5 more
doaj +1 more source